PROPRANOLOL HYDROCHLORIDE (propranolol hydrochloride) by ANI Pharmaceuticals is mechanism of action the mechanism of the antihypertensive effect of propranolol has not been established. Approved for common migraine headache, tremor associated with parkinsonism, the management of hypertension and 6 more indications. First approved in 1988.
Drug data last refreshed 18h ago
Mechanism of Action The mechanism of the antihypertensive effect of propranolol has not been established. Factors that may contribute to the antihypertensive action include: (1) decreased cardiac output, (2) inhibition of renin release by the kidneys, and (3) diminution of tonic sympathetic nerve…
Worked on PROPRANOLOL HYDROCHLORIDE at ANI Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer